nach oben

Sleep and Breathing

Erschienen in:

22.06.2020 | Sleep Breathing Physiology and Disorders • Original Article

Serum periostin and TNF-α levels in patients with obstructive sleep apnea-hypopnea syndrome

verfasst von: Lei Ji, Yanan Liu, Pingli Liu, Guijuan Ji, Jun He, Yuying Gan, Shuyang Zhu, Bi Chen, Wenhui Zhang

Erschienen in: Sleep and Breathing | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Obstructive sleep apnea-hypopnea syndrome (OSAHS) may cause pulmonary diseases, and periostin plays an important role on the development of pulmonary diseases. In addition, periostin and pro-inflammatory cytokine TNF-α can regulate each other in vivo. This study aimed to observe the changes of serum periostin and TNF-α levels in patients with OSAHS compared with healthy volunteers and to investigate their correlation.

Methods

A convenience sample of 67 patients with OSAHS in our hospital from December 2018 to December 2019 was selected and categorized into mild, moderate, and severe groups according to apnea-hypopnea index by polysomnography. In addition, 21 healthy volunteers were selected as the control group. Serum levels of periostin and TNF-α were determined by enzyme-linked immunosorbent assay (ELISA). Results were analyzed using the SPSS software.

Results

Both serum periostin and TNF-α levels in all the three OSAHS groups were higher than those of the control group and increased with severity of OSAHS. The severe group had significantly higher serum periostin and TNF-α levels than the mild and moderate groups (p < 0.05). For patients with OSAHS, serum periostin and TNF-α levels positively correlated with the apnea-hypopnea index (AHI) (p < 0.01) and negatively correlated with the lowest saturation oxygen (LSaO₂) and mean saturation oxygen (MSaO₂) (both p < 0.01). In addition, there was a positive correlation between serum periostin and TNF-α levels in patients with OSAHS (p < 0.001).

Conclusions

Serum periostin and TNF-α levels were significantly increased in patients with OSAHS and may serve as a potential biomarker for severity of OSAHS. These findings suggest that it may be fruitful to study the role of periostin and TNF-α in OSAHS-induced pulmonary diseases.

Qaseem A, Holty JC, Owens DK, Dallas P, Starkey M, Shekelle P (2013) Management of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 159:471–483CrossRef

McNicholas WT, Bonsignore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29:156–178CrossRef

Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP (2010) Pathophysiology of sleep apnea. Physiol Rev 90:47–112CrossRef

Young T, Peppard PE, Taheri S (2005) Excess weight and sleep-disordered breathing. J Appl Physiol 99:1592–1599CrossRef

Dean RT, Wilcox I (1993) Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep 16:S15–S32CrossRef

Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939CrossRef

Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034–2041CrossRef

Westergren-Thorsson G, Larsen K, Nihlberg K, Andersson-Sjöland A, Hallgren O, Marko-Varga G, Bjermer L (2010) Pathological airway remodelling in inflammation. Clin Respir J 4:1–8CrossRef

Knight D (2001) Epithelium–fibroblast interactions in response to airway inflammation. Immunol Cell Biol 79:160–164CrossRef

10.

Bonnet N, Garnero P, Ferrari S (2016) Periostin action in bone. Mol Cell Endocrinol 432:75–82CrossRef

11.

Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J (2008) Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 283:17991–18001CrossRef

12.

Idolazzi L, Ridolo E, Fassio A, Gatti D, Montagni M, Caminati M, Martignago I, Incorvaia C, Senna G (2017) Periostin: the bone and beyond. Eur J Intern Med 38:12–16CrossRef

13.

Liu AY, Zheng H, Ouyang G (2014) Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol 37:150–156CrossRef

14.

Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, Ellwanger A, Sidhu SS, Dao-Pick TP, Pantoja C, Erle DJ, Yamamoto KR, Fahy JV (2007) Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci 104:15858–15863CrossRef

15.

Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Kawayama T, Fujimoto K, Ohshima K, Shiraishi H, Uchida M, Ono J, Ohta S, Kato S, Izuhara K, Aizawa H (2011) Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 37:1119–1127CrossRef

16.

Nakajima M, Honda T, Miyauchi S, Yamazaki K (2014) Th2 cytokines efficiently stimulate periostin production in gingival fibroblasts but periostin does not induce an inflammatory response in gingival epithelial cells. Arch Oral Biol 59:93–101CrossRef

17.

Sozmen M, Devrim AK, Kabak YB, Devrim T (2019) Periostin alters transcriptional profile in a rat model of isoproterenol-induced cardiotoxicity. Hum Exp Toxicol 38:255–266CrossRef

18.

Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG (2017) Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of sleep medicine clinical practice guideline. J Clin Sleep Med 13:479–504CrossRef

19.

Meslier N, Gagnadoux F, Giraud P, Person C, Ouksel H, Urban T, Racineux JL (2003) Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 22:156–160CrossRef

20.

Kanemitsu Y, Matsumoto H, Izuhara K, Tohda Y, Kita H, Horiguchi T, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Izuhara Y, Ono J, Ohta S, Tamari M, Hirota T, Yokoyama T, Niimi A, Mishima M (2013) Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin Immunol 132:305–312CrossRef

21.

Generoso A, Oppenheimer J (2020) Asthma/obstructive pulmonary disease overlap: update on definition, biomarkers, and therapeutics. Curr Opin Allergy Clin Immunol 20:43–47CrossRef

22.

Desai M, Oppenheimer J, Tashkin DP (2017) Asthma-chronic obstructive pulmonary disease overlap syndrome: what we know and what we need to find out. Ann Allergy Asthma Immunol 118:241–245CrossRef

23.

He ZH, Domany KA, Nava-Guerra L, Khoo MCK, DiFrancesco M, Xu YF, McConnell K, Hossain MM, Amin R (2019) Phenotype of ventilatory control in children with moderate to severe persistent asthma and obstructive sleep apnea. Sleep 42:UNSP zsz130CrossRef

24.

Ding X, Yu C, Liu Y, Yan S, Li W, Wang D, Sun L, Han Y, Li M, Zhang S, Yun F, Zhao H, Li Y (2014) Chronic obstructive sleep apnea accelerates pulmonary remodeling via TGF-β/miR-185/CoLA1 signaling in a canine model. Oncotarget 7:57545–57555

25.

Broytman O, Braun RK, Morgan BJ, Egelow DF, Hsu PN, Mei LS, Koya AK, Eldridge M, Teodorescu M (2015) Effects of chronic intermittent hypoxia on allergen-induced airway inflammation in rats. Am J Respir Cell Mol Biol 52:162–170CrossRef

26.

Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N, Kudo A (2010) Incroporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chen 285:2028–2039CrossRef

27.

O’Dwyer DN, Moore BB (2017) The role of periostin in lung fibrosis and airway remodeling. Cell Mol Life Sci 74:4305–4314CrossRef

28.

Li NF, Yao XG, Zhu J, Yang J, Liu KJ, Wang YC, Wang XL, Zu FY (2010) Higher levels of plasma TNF-α and neuropeptide Y in hypertensive patients with obstructive sleep apnea syndrome. Clin Exp Hypertens 32:54–60CrossRef

29.

Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, Yamamoto M, Mitsuru A (2004) Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126:1473–1479CrossRef

30.

Luo Y, Qu H, Wang H, Wei H, Wu J, Duan Y, Liu D, Deng H (2016) Plasma periostin levels are increased in Chinese subjects with obesity and type 2 diabetes and are positively correlated with glucose and lipid parameters. Mediat Inflamm 2016:6423637

31.

Amara S, Lopez K, Banan B, Brown SK, Whalen M, Myles E, Lvy MT, Johnson T, Schey KL, Tiriveedhi V (2015) Synergistic effect of proinflammatory TNF-α and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis. Mol Immunol 64:26–35CrossRef

Titel: Serum periostin and TNF-α levels in patients with obstructive sleep apnea-hypopnea syndrome
verfasst von: Lei Ji
Yanan Liu
Pingli Liu
Guijuan Ji
Jun He
Yuying Gan
Shuyang Zhu
Bi Chen
Wenhui Zhang
Publikationsdatum: 22.06.2020
Verlag: Springer International Publishing
Erschienen in: Sleep and Breathing / Ausgabe 1/2021
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-020-02124-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Serum periostin and TNF-α levels in patients with obstructive sleep apnea-hypopnea syndrome